Therapeutic Asset Ratings
1,174 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
aciclovir
Lymphoblastic Lymphoma
City of Hope Medical Center
P2
CCC
(55)
aciclovir
Myelodysplastic Syndrome
City of Hope Medical Center
P2
CCC
(55)
aciclovir
Myelofibrosis
City of Hope Medical Center
P2
CCC
(55)
aciclovir
Non-Hodgkin Lymphoma
City of Hope Medical Center
P2
CCC
(55)
Busulphan
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
City of Hope Medical Center
P2
CCC
(55)
CIS-DIAMMINEDICHLOROPLATINUM II
Acute Myeloid Leukemia
City of Hope Medical Center
P2
CCC
(55)
Copanlisib
Mantle Cell Lymphoma
City of Hope Medical Center
P2
CCC
(55)
Epcoritamab
High Grade B-Cell Lymphoma
City of Hope Medical Center
P2
CCC
(55)
Epcoritamab
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
City of Hope Medical Center
P2
CCC
(55)
Fludarabine
Malignant Pancreatic Neoplasm
City of Hope Medical Center
P2
CCC
(55)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER
Breast Cancer
City of Hope Medical Center
P2
CCC
(55)
Leflunomide
Malignant Pancreatic Neoplasm
City of Hope Medical Center
P2
CCC
(55)
Letermovir
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
City of Hope Medical Center
P2
CCC
(55)
Letermovir
Lymphoblastic Lymphoma
City of Hope Medical Center
P2
CCC
(55)
Letermovir
Myelodysplastic Syndrome
City of Hope Medical Center
P2
CCC
(55)
Letermovir
Myelofibrosis
City of Hope Medical Center
P2
CCC
(55)
Letermovir
Non-Hodgkin Lymphoma
City of Hope Medical Center
P2
CCC
(55)
Loncastuximab Tesirine
Primary Mediastinal Large B-Cell Lymphoma
City of Hope Medical Center
P2
CCC
(55)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine
Lymphoblastic Lymphoma
City of Hope Medical Center
P2
CCC
(55)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine
Myelodysplastic Syndrome
City of Hope Medical Center
P2
CCC
(55)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine
Myelofibrosis
City of Hope Medical Center
P2
CCC
(55)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine
Non-Hodgkin Lymphoma
City of Hope Medical Center
P2
CCC
(55)
Nemtabrutinib
Marginal Zone Lymphoma
City of Hope Medical Center
P2
CCC
(55)
Recombinant Human Granulocyte Colony-Stimulating Factor
Myelodysplastic Syndrome
City of Hope Medical Center
P2
CCC
(55)
Ruxolitinib Phosphate
Myelodysplastic Syndrome
City of Hope Medical Center
P2
CCC
(55)
Showing 376 to 400 of 1,174 assets
Previous
Page 16 of 47
Next